Heat shock protein-60 expression was significantly correlated with the prognosis of lung adenocarcinoma

Journal of Surgical Oncology

Volumn 104, Issue 6, 2011, Pages 598-603

  Xu, Xin ^a,b,c   Wang, Wei ^a   Shao, Wenlong ^a,b,c   Yin, Weiqiang ^b,c   Chen, Hanzhang ^b,c   Qiu, Yuan ^b,c   Mo, Mingcong ^b   Zhao, Jin ^c   Deng, Qiuhua ^b,c   He, Jianxing ^a,b,c  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

heat shock protein 60; immunohistochemistry; lung adenocarcinoma

Indexed keywords

HEAT SHOCK PROTEIN 60;

ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CORRELATIONAL STUDY; CYTOPLASM; DISEASE FREE SURVIVAL; FEMALE; FUNCTIONAL STATUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE;

ADENOCARCINOMA; AGED; CHAPERONIN 60; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL RATE;

EID: 80053609583     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21992     Document Type: Article

References (40)

1. Jemal A, Bray F, Center MM, et al.: Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Little AG, Gay EG, Gaspar LE, et al.: National survey of non-small cell lung cancer in the United States: Epidemiology, pathology and patterns of care. Lung Cancer 2007; 57: 253-260. (Pubitemid 47285417)
3. Shao WL, Wang DY, He JX,: The role of gene expression profiling in early-stage non-small cell lung cancer. J Thorac Dis 2010; 2: 89-99.
4. Jemal A, Murray T, Ward E, et al.: Cancer statistics, 2005. CA Cancer J Clin 2005; 55: 10-30. (Pubitemid 40310185)
5. Pantel K, Izbicki J, Passlick B, et al.: Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 1996; 347: 649-653. (Pubitemid 26076131)
6. Ruffato A, Mattioli S, Pileri S, et al.: Do bone marrow isolated tumor cells influence long-term survival of non-small cell lung cancer? Eur J Cardiothorac Surg 2009; 35: 463-468.
7. Singhal S, Vachani A, Antin-Ozerkis D, et al.: Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: A review. Clin Cancer Res 2005; 11: 3974-3986. (Pubitemid 40791561)
8. Li J, Dai CH, Chen P, et al.: Survival and prognostic factors in small cell lung cancer. Med Oncol 2010; 27: 73-81.
9. Tomita M, Shimizu T, Ayabe T, et al.: Prognostic significance of tumour marker index based on preoperative CEA and CYFRA21-1 in non-small cell lung cancer. Anticancer Res 2010; 30: 3099-3102.
10. Tian T, Hao J, Xu A, et al.: Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis. Cancer Sci 2007; 98: 1265-1274. (Pubitemid 46993548)
11. Larsen JE, Pavey SJ, Passmore LH, et al.: Gene expression signature predicts recurrence in lung adenocarcinoma. Clin Cancer Res 2007; 13: 2946-2954. (Pubitemid 46849569)
12. Nakamura N, Kobayashi K, Nakamoto M, et al.: Identification of tumor markers and differentiation markers for molecular diagnosis of lung adenocarcinoma. Oncogene 2006; 25: 4245-4255. (Pubitemid 44079459)
13. Shibata T, Uryu S, Kokubu A, et al.: Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: Its association with clinicopathologic features. Clin Cancer Res 2005; 11: 6177-6185. (Pubitemid 41262945)
14. Liu YF, Xiao ZQ, Li MX, et al.: Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma. J Pathol 2009; 217: 54-64.
15. Sebastiani V, Botti C, Di Tondo U, et al.: Tissue microarray analysis of FAS, Bcl-2, Bcl-x, ER, PgR, Hsp60, p53 and Her2-neu in breast carcinoma. Anticancer Res 2006; 26: 2983-2987. (Pubitemid 44161790)
16. Castilla C, Congregado B, Conde JM, et al.: Immunohistochemical expression of Hsp60 correlates with tumor progression and hormone resistance in prostate cancer. Urology 2010; 76: 1017. e1-6.
17. Cappello F, David S, Rappa F, et al.: The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastases. BMC Cancer 2005; 5: 139.
18. Fan GK, Chen J, Ping F, et al.: Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues. Oral Oncol 2006; 42: 147-1153.
19. Tanaka A, Kamada T, Yokota K, et al.: Helicobacter pylori heat shock protein 60 antibodies are associated with gastric cancer. Pathol Res Pract 2009; 205: 690-694.
20. Langer R, Ott K, Specht K, et al.: Protein expression profiling in esophageal adenocarcinoma patients indicates association of heat-shock protein 27 expression and chemotherapy response. Clin Cancer Res 2008; 14: 8279-8287.
21. Qi T, Han J, Cui Y, et al.: Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas. J Clin Pathol 2008; 61: 49-58. (Pubitemid 351158225)
22. Cappello F, Di Stefano A, David S, et al.: Hsp60 and Hsp10 down-regulation predicts bronchial epithelial carcinogenesis in smokers with chronic obstructive pulmonary disease. Cancer 2006; 107: 2417-2424. (Pubitemid 44748525)
23. Cappello F, Di Stefano A, D'Anna SE, et al.: HSP60 immunopositivity as a novel biomarker of bronchial carcinogenesis. Lancet Oncol 2005; 6: 816. (Pubitemid 41430724)
24. Goldstraw P, Crowley J, Chansky K, et al.: The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007; 2: 706-714. (Pubitemid 47357522)
25. Travis WD,: World Health Organization, International Agency for Research on Cancer, International Academy of Pathology International Association for the Study of Lung Cancer. Pathology and genetics of tumours of the lung, pleura, thymus, and heart. Lyon: LARC Press; 2004.
26. Li Z, Zhao X, Bai S, et al.: Proteomics identification of cyclophilin a as a potential prognostic factor and therapeutic target in endometrial carcinoma. Mol Cell Proteomics 2008; 7: 1810-1823.
27. Devbhandari MP, Yang SS, Quennell P, et al.: Lung cancer resection rate in south Manchester: is it comparable to international standards? Results: of a prospective tracking study. Interact Cardiovasc Thorac Surg 2007; 6: 712-714. (Pubitemid 350291682)
28. Laroche C, Wells F, Coulden R, et al.: Improving surgical resection rate in lung cancer. Thorax 1998; 53: 445-449. (Pubitemid 28308057)
29. Ottavio R, Luca C, Silvia C, et al.: Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: Prognostic significance. Eur J Cardiothorac Surg 2007; 32: 863-867.
30. Zhu CQ, Shih W, Ling CH, et al.: Immunohistochemical markers of prognosis in non-small cell lung cancer: A review and proposal for a multiphase approach to marker evaluation. J Clin Pathol 2006; 59: 790-800. (Pubitemid 44211740)
31. Au NH, Cheang M, Huntsman DG, et al.: Evaluation of immunohistochemical markers in non-small cell lung cancer byunsupervised hierarchical clustering analysis: A tissue microarraystudy of 284 cases and 18 markers. J Pathol 2004; 204: 101-109. (Pubitemid 39214487)
32. Kirchhoff SR, Gupta S, Knowlton AA,: Cytosolic heat shock protein 60, apoptosis, and myocardial injury. Circulation 2002; 105: 2899-2904. (Pubitemid 34666105)
33. Xanthoudakis S, Roy S, Rasper D, et al.: HSP60 accelerates the maturation of pro-caspase-3 by upstream activator proteases during apoptosis. EMBO J 1999; 18: 2049-2056. (Pubitemid 29179162)
34. Shan YX, Liu TJ, Su HF, et al.: Hsp10 and Hsp60 modulate Bcl-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells. J Mol Cell Cardiol 2003; 35: 1135-1143.
35. Thomas X, Campos L, Mounier C, et al.: Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia. Leuk Res 2005; 29: 1049-1058. (Pubitemid 40982599)
36. Lebret T, Watson RW, Molinie V, et al.: Heat shock proteins HSP27, HSP60, HSP70, and HS P90: Expression in bladder carcinoma. Cancer 2003; 98: 970-977. (Pubitemid 37022097)
37. Faried A, Sohda M, Nakajima M, et al.: Expression of heat-shock protein Hsp60 correlated with the apoptotic index and patient prognosis in human oesophageal squamous cell carcinoma. Eur J Cancer 2004; 40: 2804-2811. (Pubitemid 39574735)
38. Schneider J, Jimenez E, Marenbach K, et al.: Immunohistochemical detection of HSP60-expression in human ovarian cancer. Correlation with survival in a series of 247 patients. Anticancer Res 1999; 19: 2141-2146. (Pubitemid 29392784)
39. Uozaki H, Ishida T, Kakiuchi C, et al.: Expression of heat shock proteins in osteosarcoma and its relationship to prognosis. Pathol Res Pract 2000; 196: 665-673.
40. Cornford PA, Dodson AR, Parsons KF, et al.: Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res 2000; 60: 7099-7105. (Pubitemid 32059190)